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The aim of the study was to investigate the molecular epidemiology of Staphylococcus epidermidis in Iranian
hospitals and to compare the genotypes with a previously characterized collection of >1,300 S. epidermidis
isolates of nosocomial and community origin from Northern Europe, Australia, and USA. In total, 82 clinical
S. epidermidis isolates from three Iranian hospitals were examined by multilocus sequence typing, pulsed-field
gel electrophoresis (PFGE) and staphylococcal cassette chromosome mec (SCCmec) typing. In addition, an-
timicrobial susceptibility, the presence of the ica operon, and the predilection to biofilm formation were
assessed. Three predominant PFGE clones were found. The PFGE patterns of the most common sequence type
(PFGE type 040-ST2) showed 80% similarity to multidrug-resistant S. epidermidis (MDRSE) clinical isolates
from eight hospitals in Northern Europe. The second most common (PFGE 024-ST22) showed an unique PFGE
pattern, whereas the third most predominant genotype (PFGE 011-ST5) proved indistinguishable to the PFGE
Co-ST5 identified in five hospitals in Northern Europe. In conclusion, the study documented the dissemination
of three MDRSE clones within and between hospitals in Iran and revealed an intercontinental spread of two
clonal multidrug-resistant lineages (ST2 and ST5) in the hospital environment. Isolates of the predominant
clones were significantly more frequently associated with multidrug-resistance and biofilm formation compared
to nonclonal isolates. Further studies are needed to explore and characterize the genetic traits that enable these
successful MDRSE clones to persist and disseminate worldwide in the healthcare settings.
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Introduction
In recent years, medical progress, such as the extensiveuse of medical devices as well as use of antibiotics and dis-
infectants, has led to the emergence of Staphylococcus epi-
dermidis as an important nosocomial pathogen.1–3 The striking
ability for biofilm formation and the high rate of reduced sus-
ceptibility to antimicrobials are two important strategies used by
S. epidermidis for persistence and survival in the hospital set-
tings. Additionally, its genome flexibility allows for frequent
recombination and acquisition of mobile genetic elements,
which is another trait for nosocomial S. epidermidis strains.4–6
Notably, at present more than 70% of healthcare-associated
S. epidermidis are methicillin-resistant, which is of concern
and limits the options for effective antimicrobial treatment.7–9
Resistance to methicillin is mediated by the mecA gene
carried on the staphylococcal cassette chromosome mec
(SCCmec). It has been suggested that the frequent loss and
acquisition of SCCmec elements in S. epidermidis accounts for
the prevalence of different SCCmec types in closely related
strains.6,7
Several studies have reported the intrahospital and occa-
sional interhospital endemic occurrence of a fewwell-adapted,
highly resistant S. epidermidis lineages.4,10–12 Moreover, there
is limited evidence of wide geographic dissemination of epi-
demic clonal lineages of S. epidermidis between countries.13–16
To obtain amore complete picture of the worldwide occurrence
and spread of healthcare-associated S. epidermidis lineages,
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more molecular epidemiology data is needed from the Middle
East, for example from the most populous country in this re-
gion, Iran. In this respect, molecular typing can help to identify
clonal or sporadic dissemination and subsequently can be
helpful to address more effectively the related infections.
Pulsed-field gel electrophoresis (PFGE) has been utilized as the
most discriminatory method for genotyping of staphylococcal
strains and widely been used for hospital outbreak investiga-
tions.17 To predict long-term evolutionary relationships, mul-
tilocus sequence typing (MLST) is the recommendedmethod.6
This study was aimed to characterize clinical S. epi-
dermidis isolates from Iranian hospitals, using both geno-
typic and phenotypic methods and to track the epidemic
spread of these isolates. The Iranian isolates were compared
with a previously characterized collection of S. epidermidis
strains from nosocomial and community origin in northern
Europe, Australia, and USA.
Materials and Methods
Bacterial isolates
From a total of 177 clinical coagulase-negative staphy-
lococci (CoNS) collected from February 2012 to December
2013, 82 nonrepetitive S. epidermidis isolates were included
in this study. This collection contained 42 isolates from a
pediatric teaching hospital in Tabriz (Tabriz, north-western
Iran, coded ‘‘T’’) and 40 isolates from two hospitals in
Tehran: 21 isolates from a referral pediatric university-
affiliated hospital (Tehran, central Iran, coded ‘‘MT’’), and
19 isolates from a tertiary care hospital (coded ‘‘M’’). The
majority of the isolates, 77% (63/82), were collected from
neonates and children (£10 years of age) (Table 1).
Most isolates, 67% (55/82), were obtained from blood
cultures and <10% each originated from other sources
(Table 1). Clinically significant isolates were determined in
accordance with criteria defined by Center for Disease
Control and Prevention for determination of nosocomial
infection18 and those proposed by Stoll et al. for diagnosis
of invasive blood culture isolates in neonates.19 S. epi-
dermidis isolates from a monobacterial positive blood cul-
ture were defined as infecting isolates in neonates when
combined with C-reactive protein >10mg/L. For non-
neonates two positive cultures out of a set of two separately
collected bottles were defined as infecting isolates. Also,
S. epidermidis from normally sterile internal fluids or from
foreign bodies in pure primary cultures were considered as
infecting isolates.
Species identification and matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
Identification of CoNS was performed primarily using
standard laboratory methods with further identification to
species level by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS). In
summary, isolates were cultured overnight at 35C in air on
blood agar as previously described.20,21 Colonies of bacteria
were identified using the MALDI-TOF MS according to the
manufacturer’s protocol (Bruker Daltonics).
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed by disk
diffusion using the following antibiotics: gentamicin (10mg),
erythromycin (15mg), clindamycin (2mg), ciprofloxacin (5mg),
cefoxitin (30mg), trimethoprim/sulfamethoxazole (1.25/
23.75mg), fusidic acid (10mg), and linezolid (30mg) (MAST).
For vancomycin, minimum inhibitory concentration (MIC)
value was determined using the Liofilchem MIC test strip
(Liofilchem). The results were interpreted according to crite-
ria defined by the Clinical and Laboratory Standard Institute
(CLSI) guidelines.22 For fusidic acid, susceptibility breakpoint
proposed by Deveci et al. was used.23 Multidrug-resistance
(MDR)was defined as resistance to at least four different classes
of antibiotics.10
Semiquantitative biofilm assay
Biofilm formation was quantified using a microtiter plate
assay as described previously.24 Overnight grown cultures
were diluted 1:100 in trypticase soy broth (Merck) supple-
mented with 0.25% glucose, of which 200ml was inoculated
into 96-well microtiter plates (Greiner CELLSTAR Bio-One
B.V). After incubation at 37C for 24 hours, the bacterial
suspensions were gently removed and the wells were
Table 1. Characteristics of Hospitals and the 82 Staphylococcus epidermidis
Isolates Included in This Study
Hospital
Beds
(No.) City
Isolates
(No.)
Gender
(F/M) (No.)
Age
(min, max) Source of specimens (No.)
T 300 Tabriz 42 19/23 3d-7y B(30), T(8), C(2), S(1), P(1)
MT 300 Tehran 21 12/9 3d-5y B(10), W(5), C(4), E(2),
M 1,000 Tehran 19 11/8 20d-90y B(15), C(1), CSF(1), S(1), U(1)
Total 82 42/40 B(55), T(8), C(7), W(5), E(2), CSF(1), P(1), S(2), U(1)
T, a pediatric teaching hospital; MT, a referral pediatric university-affiliated hospital; M, a tertiary care hospital.
F, female; M: male; d, days; y, years; B, blood; C, catheter; CSF, cerebrospinal fluid; E, eye; P, peritoneal fluid; S, shunt; T, tracheal tube;
U, urine; W, wound.
FIG. 1. Analysis of the genetic similarity of 82 Staphylococcus epidermidis isolates using PFGE. The horizontal upper bar
represents genetic similarity (percent). The dotted lines in the center represent digitalized transformation of the PFGE-DNA
pattern. Isolate code/hospital, gender, age, wards, infection/noninfection, source of sample, PFGE type, SCCmec type, ST,
MDR phenotype, ica gene presence, and biofilm production are described in the columns to the right. PFGE, pulsed-field
gel electrophoresis; ST, sequence type; MDR, multidrug-resistant; SCCmec, staphylococcal cassette chromosome mec.
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washed three times with 200 ml saline to remove bacteria
that had not adhered to the biofilm before staining with 0.1%
safranin (Merck) solution. After 30 seconds, the excessive
dye was removed by rinsing the wells three times with
200 ml sterile distilled water. The plate was allowed to dry
and the biofilm-bound-safranin was extracted by addition
200 ml of 95% ethanol and the absorbance was measured
at 490 nm using a microplate reader (BioTek, ELX 800;
Winooski). An optical density ‡ 0.17 was considered as biofilm
formation. S. epidermidis ATCC 12228 and S. epidermidis
RP62A were used as negative and positive controls, re-
spectively.
Detection of the ica operon
DNA extraction was performed by the Cetyitrime-
thylammonium Bromide (CTAB) method25 and all isolates
were examined for the presence of ica operon by PCR
amplification.26
SCCmec typing
All mecA-positive isolates detected by PCR27were char-
acterized as SCCmec types I-V using multiplex PCR as
previously described.28 Isolates, which showed unrelated
patterns, were classified as nontypeable.
PFGE and MLST
DNA was prepared from 3mL S. epidermidis overnight
cultures in Todd Hewitt broth (Difco Laboratories) as pre-
viously described.15 The DNA was digested using SmaI
(Thermo Scientific) and the DNA fragments were separated
by PFGE in a GenePath apparatus (Bio-Rad Laboratories)
using Program 14, for 19.7 hours according to the manu-
facturer’s instructions (Bio-Rad). Gels were stained in 1mg/
L ethidium bromide, destained, and photographed under UV
illumination. Genetic similarity between isolates was cal-
culated using GelCompar II 4.0 (Applied Maths) using the
Dice coefficient, and the unweighted pair group method
with arithmetic mean (UPGMA) with 1.3% tolerance and
0.8% optimization settings. S. aureus NCTC 8325 was in-
cluded as a reference in every sixth to seventh lane to allow
normalization of the electrophoretic pattern. Band sizes
below 36 kb were not analysed.29 PFGE types were visually
identified according to established criteria, isolates with
more than three-band variation in the PFGE pattern were
defined as genetically unrelated.30 This corresponded to a
similarity coefficient of 90% using the cluster analysis.
PFGE types were assigned arbitrary numbers (001, 002,
003.) and isolates with 1–3 band differences were assigned
to PFGE subtypes (numbers with letter codes, 001a, 001b,
001c.).
MLST was performed as previously described.15 Selected
isolates from each PFGE type that included ‡3 isolates were
analyzed by MLST. Sequence types (STs) were assigned
using the S. epidermidis MLST database (www.mlst.net).
The PFGE patterns of the 82 studied isolates were
compared with a previously in part described compilation
of 1,315 S. epidermidis isolates,11–13,15,31 of which >90%
were methicillin-resistant S. epidermidis (MRSE). The
collection contained healthcare-associated S. epidermidis
collected from 1994 to 2012 at the Umea˚ University
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Hospital (498 isolates), the O¨stersund Hospital in northern
Sweden (479 isolates), as well as isolates from nine other
northern European hospitals (149 isolates) and Royal Perth
Hospital, Australia (27 isolates). In addition, a collection
of nonhealthcare-associated nasal or hand colonization
S. epidermidis isolates were included from Umea˚ (124
isolates) and VA Medical Center, Medical University of
South Carolina, Charleston, SC (38 isolates kindly pro-
vided by Dr. Joseph F John). All PFGE analysis in the
present study as in the PFGE collection was carried out at
the Department of Clinical Microbiology, Umea˚ University
Hospital, Umea˚, Sweden.11–13,15,31
Ethical approval. The study was approved by the regional
ethics board at Tabriz University of Medical Sciences.
Statistical methods
Statistical analysis was performed using the software
IBM SPSS Statistics version 21. The chi-square test was
used to compare the characteristics of isolates in predomi-
nant clonal genotypes with nonclonal ones. A p-value of
<0.05 was considered statistically significant.
Results
Eighty-two isolates of S. epidermidis were included. The
distribution of isolates in infecting (I) and noninfecting
(N) groups was 73% (60/82) and 27% (22/82), respectively
(Table 2). Overall, 74% (61/82) of the S. epidermidis iso-
latesweremethicillin-resistant. The antimicrobial resistance
rates were as follows: erythromycin (78%), trimethoprim/
sulfamethoxazole (78%), clindamycin (76%), ciprofloxacin
(57%), gentamicin (49%), and fusidic acid (27%). No resis-
tance to vancomycin and/or linezolid was found. MDR phe-
notype was found in 67% (55/82) of the isolates (Table 2).
Molecular analysis
DNA macrorestriction analysis of the 82 isolates revealed
42 different PFGE types, of which 34 types were singletons
(Fig. 1). Three dominant PFGE types were detected (pre-
sented with corresponding ST-type); PFGE type 040-ST2,
PFGE 024-ST22, and PFGE 011-ST5, which comprised
21% (17 isolates), 13% (11 isolates), and 11% (9 isolates)
(Table 3). These PFGE types included five, five and four
subtypes, respectively. In addition, PFGE 031-ST32 in-
cluded three isolates and each of four other PFGE types
included two isolates (PFGE 007, 022, 028, 041). PFGE
040-ST2 and PFGE 011-ST5 were detected in all three
hospitals, whereas PFGE 024-ST22 was identified in two
hospitals (T and M). Furthermore, two novel single-locus
variants, belonging to sequence types of ST5 and ST2, were
identified and assigned ST592 and ST593, respectively in
the MLST database (www.mlst.net). The eBURST algo-
rithm was used to assess the relationship between predom-
inant sequence types identified in this study with the
available database in MLST website (Fig. 2).
Approximately 54% (44/82) of the isolates harbored the
ica operon of which 64% (28/44) were distributed among
ST2 and ST22 (Table 3). No significant difference in the
carriage of the ica genes were found between infecting and
noninfecting groups ( p > 0.05).
The SCCmec analysis of 61 mecA-positive isolates revealed
that SCCmec type IVwas themost prevalent (54%), followed by
type I (15%), type II (10%), type V (3%), and type I+ III (2%).
Ten isolates (16%) were not typable according to SCCmec
analysis. PFGE type 044-ST2 isolateswere not associatedwith a
specific SCCmec type. Conversely, the majority of isolates in
ST22 and ST5 (14/20) carried SCCmec IV (Fig. 1).
The three dominant PFGE types revealed no significant
difference in methicillin resistance or MDR phenotype
( p > 0.05). However, ST2 isolates were significantly more
FIG. 2. eBURST analysis of S. epidermidis STs observed in this study compared with STs in the multilocus sequence
typing database. The numbers in the figure represent the sequence types and ST592 and ST593 represent the novel sequence
types found in the present study.
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frequently resistant to fusidic acid ( p < 0.001) and genta-
micin ( p = 0.01) in comparison with those belonging to
PFGE 024-ST22 and 011-ST5 (Table 3).
PFGE 011-ST5 proved indistinguishable to the PFGE Co-
ST5 previously described in clinical samples from five
hospitals in Northern Europe (Umea˚, O¨stersund, Trondheim,
Copenhagen, and Va¨xjo¨) in 2001–2011.12,15 The remaining
41 PFGE types, including the second most common PFGE
024-ST22, showed unique patterns compared to the 1,315
S. epidermidis isolates in the database. However, PFGE 040-
ST2 demonstrated 80% similarity to PFGE B-ST2 previ-
ously described in MDRSE clinical isolates obtained from
eight hospitals in Northern Europe during 2003–2008.15
Phenotypic characterization of predominant
and sporadic PFGE types
The isolates in the three predominant PFGE types showed
a significantly increased predisposition to biofilm formation
( p= 0.001) and were significantly more commonly associ-
ated with ica carriage ( p < 0.001) and the MDR phenotype
( p< 0.001) compared to nonclustered types. However, no
significant association was found in methicillin resistance or
clinical significance between these two groups ( p = 0.3;
p = 1.0) (Table 3).
Discussion
PFGE analysis of 82 clinical S. epidermidis isolates from
Iranian hospitals identified three predominant MDRSE
clones among isolates with high genetic diversity. The
presence of indistinguishable PFGE types in the three hos-
pitals 600 km apart may be explained by the fact that the two
examined hospitals in Tehran are large hospitals with patient
admissions from all over the country.
The three predominating sequence types belonged to
previously well-known healthcare-associated MRSE geno-
types. In accordance with other reports,2,4,8,10,13,32,33 all ST2
were MDR and ica positive. Our results are in agreement
with a Swedish report that reported 86% MDR among ST2
isolates4 and two studies from China that reported that all
ST2 isolates were ica positive.8,33 Hence, these traits appear
to be important factors in ST2 ability to disseminate
worldwide. Also ST2 isolates were associated with intensive
care units (esp. neonatal ICU), highlighting its adaptability
to ward units associated with long period of stay, use of
invasive procedures, and high antibiotic pressure, which
promote selection of strains and persistence.
The documented interhospital spread of ST22, a single
locus variant of ST2, is particularly concerning since
linezolid-resistant S. epidermidis (LRSE) isolates belonging
to ST22 have been reported in six Greek hospitals.34
However, LRSE was not detected in this study and whether
or not LRSE is present in Iranian hospitals requires further
study.
All except one isolate in the three predominant genotypes
in the present study were MDR. Hence, acquisition of an-
tibiotic resistance might be an important factor for these
genotypes to establish and persist in the hospital environ-
ments. This reduces the number of available antimicrobial
agents for treatment, increases cost, and the risk of therapy
failure. Antimicrobial stewardship intervention and im-
plementation of strict infection control procedures may
T
a
b
l
e
3
.
C
o
m
pa
r
is
o
n
B
e
t
w
e
e
n
C
h
a
r
a
c
t
e
r
is
t
ic
s
o
f
S
.
e
pi
d
e
r
m
id
is
Is
o
l
a
t
e
s
in
P
r
e
d
o
m
in
a
n
t
C
l
o
n
a
l
G
e
n
o
t
y
pe
s
a
n
d
N
o
n
c
l
o
n
a
l
O
n
e
s
S
.
ep
id
er
m
id
is
P
F
G
E
ty
p
es
N
o
.
(%
)
m
ec
A
g
en
e
N
o
.
(%
)
Ic
a
g
en
e
N
o
.
(%
)
B
io
fi
lm
fo
rm
a
ti
o
n
a
N
o
.
(%
)
A
n
ti
b
io
ti
c
re
si
st
a
n
ce
N
o
.
(%
)
M
D
R
N
o
.
(%
)
In
fe
ct
in
g
is
o
la
te
s
N
o
.
(%
)
C
IP
G
M
C
D
E
F
A
T
S
P
re
d
o
m
in
an
t
P
F
G
E
ty
p
es
*
3
7
(4
5
)
3
0
(8
1
)
2
8
(7
6
)
2
7
(7
3
)
3
5
(9
4
)
2
5
(6
7
)
3
7
(1
0
0
)
3
7
(1
0
0
)
1
7
(4
6
)
3
4
(9
2
)
3
6
(9
7
)
2
7
(7
3
)
*
P
F
G
E
0
4
0
-S
T
2
1
7
1
3
(7
6
)
1
7
(1
0
0
)
1
4
(8
2
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
7
(1
0
0
)
1
2
(7
1
)
*
P
F
G
E
0
1
1
-S
T
5
9
8
(8
9
)
2
(2
2
)
4
(4
4
)
7
(7
8
)
2
(2
2
)
9
(1
0
0
)
9
(1
0
0
)
0
(0
)
7
(7
8
)
8
(8
9
)
7
(7
8
)
*
P
F
G
E
0
2
4
-S
T
2
2
1
1
9
(8
2
)
9
(8
2
)
9
(8
2
)
1
1
(1
0
0
)
6
(5
4
)
1
1
(1
0
0
)
1
1
(1
0
0
)
0
(0
)
1
0
(9
1
)
1
1
(1
0
0
)
8
(7
3
)
N
o
n
cl
o
n
al
P
F
G
E
ty
p
es
4
5
(5
5
)
3
1
(6
9
)
1
6
(3
5
)
1
6
(3
5
)
1
2
(2
7
)
1
5
(3
3
)
2
5
(5
5
)
2
7
(6
0
)
5
(1
1
)
3
0
(6
7
)
1
9
(4
2
)
3
3
(7
3
)
p
-v
al
u
eb
0
.3
<0
.0
0
1
0
.0
0
1
<0
.0
0
1
0
.0
0
4
<0
.0
0
1
<0
.0
0
1
0
.0
0
1
0
.0
0
7
<0
.0
0
1
1
.0
0
0
a
B
io
fi
lm
fo
rm
at
io
n
d
et
er
m
in
ed
b
y
th
e
m
ic
ro
ti
te
r
p
la
te
as
sa
y
.
b
p
-v
al
u
e:
co
m
p
ar
is
o
n
o
f
p
re
d
o
m
in
an
t
an
d
n
o
n
cl
o
n
al
P
F
G
E
ty
p
es
.
U
si
n
g
ch
i-
sq
u
ar
e
te
st
.
A
p
-v
al
u
e
o
f
<0
.0
5
is
co
n
si
d
er
ed
st
at
is
ti
ca
ll
y
si
g
n
ifi
ca
n
t.
MOLECULAR CHARACTERIZATION OF S. EPIDERMIDIS IN IRAN 575
prevent the establishment and further spread of these
MDRSE isolates in healthcare settings.
The existence of PFGE types among distant geographic
locations indicate long-distance dissemination of these ge-
notypes.16 However, the presence of indistinguishable or
closely related PFGE types in Iran and in Northern Europe
may also reflect an independent evolution at different lo-
cations of these genotypes since direct transmission might
be less likely to occur. The transmission in and between
hospitals worldwide warrants additional studies, including
whole-genome sequencing to elucidate the relationship be-
tween these strains.35
SCCmec type IV was the prevailing among ST5 and ST22
isolates. However, the ST2 isolates revealed several different
SCCmec types, which is in agreement with Kozitskaya
et al.27 and Ahlstrand et al.4 This is in contrast to Li et al.8
who reported SCCmec type III as being the most frequent in
ST2 isolates. Recently, SCCmec type IV was identified as the
most frequent, and probably the most advantageous in rela-
tion to fitness cost, SCCmec type among S. epidermidis iso-
lates of both community and hospital origin.6
There are some limitations to our study. We classified the
isolates according to clinical significance, which is seldom
reported in other studies.4 There are several possible expla-
nations for why no difference in the distribution of genotypes
among infecting and noninfecting isolates was detected. First,
it can be due to misclassification since there are no generally
accepted criteria in this field. Second, the noninfecting iso-
lates may represent the hospital environment flora colonizing
the patients before infection. Hence, depending on the time-
frame of culture in an individual patient, identical S. epidermidis
genotypes may be classified as infecting or noninfecting iso-
lates. Third, the present cohort is small and further studies are
warranted to confirm the dynamics and relatedness between
infecting and noninfecting isolates.
Lastly, most specimens were obtained from children, in
contrast to our compilation of S. epidermidis isolates, which
mainly originates from adults. This skewness may hamper
the PFGE evaluation since children and especially neonates
have a different composition of the skin flora compared to
adults.36 However, this limitation likely had a minor effect
on the outcome of the results.
A strength of the present study is that all PFGE analysis,
including the compilation of >1,300 S. epidermidis strains,
was performed at only one laboratory, which excludes in-
terlaboratory variation that has been reported to affect the
evaluation of PFGE gels.29
In summary, this study provides an overview of the mo-
lecular characterization and distribution of clinical isolates of
S. epidermidis in Iranian hospitals. We documented the dis-
semination of MDRSE clones between three Iranian hospitals
and a global dissemination of two clonal lineages (ST2 and
ST5). Further studies are warranted to explore if interventions
such as implementation of antimicrobial stewardship and
strict infection control procedures may prevent further spread
of these MDRSE isolates in healthcare settings.
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